This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vazifeh, D.
Right arrow Articles by Labro, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vazifeh, D.
Right arrow Articles by Labro, M. T.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 1998, p. 1944-1951, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Interactions between HMR 3647, a New Ketolide, and Human Polymorphonuclear Neutrophils

D. Vazifeh,1 A. Preira,1 A. Bryskier,2 and M. T. Labro1,*

INSERM U 479, Laboratoire d'Hématologie et Immunologie, CHU X. Bichat, 75018 Paris,1 and Anti-Infective Research Department, Hoechst-Marion-Roussel, 93235 Romainville,2 France

Received 20 November 1997/Returned for modification 26 April 1998/Accepted 20 May 1998

HMR 3647, a new ketolide, is active upon intracellular pathogens. We previously demonstrated that HMR 3004 (RU 64004), another ketolide, is highly concentrated by human polymorphonuclear neutrophils (PMNs). This prompted us to evaluate whether the presence of a 3-keto group instead of an L-cladinose, a neutral sugar characteristic of erythromycin A derivatives, confers peculiar pharmacokinetic properties with regard to cellular accumulation and efflux. After incubation with the radiolabelled drug, HMR 3647 uptake was determined by a velocity gradient centrifugation technique. HMR 3647 was avidly concentrated by PMNs, without saturation, over a 3-h incubation period, with cellular-to-extracellular concentration ratios of 31 ± 4.2 at 5 min and up to 348 ± 27.1 at 180 min. About 60% of HMR 3647 was located in the granular compartment; less than 6% was associated with the membranes. HMR 3647 gradually egressed from loaded cells placed in drug-free medium. Uptake was dependent on environmental temperature (activation energy, 128 ± 9.4 kJ/mol) but not on extracellular pH. HMR 3647 displayed Michaelis-Menten saturation kinetics with a mean Vmax of 2315 ng/2.5 × 106 PMNs/5 min and a mean Km of 117 mg/liter (144 µM). As already observed with erythromycin A-derived macrolides, extracellular Ca2+ was necessary for optimal uptake of HMR 3647. Interestingly, verapamil increased the uptake of HMR 3647 at 5 min, but this was followed by gradual inhibition at later incubation times, a phenomenon probably related to stimulation of drug efflux. The impact of intracellular accumulation of HMR 3647 on PMN functions was also investigated. In contrast to other erythromycin A derivatives, HMR 3647 only weakly triggered granule exocytosis, but it inhibited superoxide anion production in a time- and concentration-dependent manner, with concentrations which inhibited 50% of control response of 55 (67 µM) (5 min) and 30 (36 µM) (30 min) mg/liter for formyl-methionyl-leucyl-phenylalanine stimulation and 117 (143 µM) (5 min) and 44 (54 µM) (30 min) mg/liter for phorbol myristate acetate stimulation.

* Corresponding author. Mailing address: INSERM U294, CHU X. Bichat, 46 rue H. Huchard, 75018 Paris, France. Phone: 33 01 40 25 85 21. Fax: 33 01 40 25 88 53. E-mail: labro{at}bichat.inserm.fr.

Antimicrobial Agents and Chemotherapy, August 1998, p. 1944-1951, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Leiva, M., Ruiz-Bravo, A., Jimenez-Valera, M. (2008). Effects of Telithromycin in In Vitro and In Vivo Models of Lipopolysaccharide-Induced Airway Inflammation. Chest 134: 20-29 [Abstract] [Full Text]  
  • Bosnar, M., Kelneric, Z., Munic, V., Erakovic, V., Parnham, M. J. (2005). Cellular Uptake and Efflux of Azithromycin, Erythromycin, Clarithromycin, Telithromycin, and Cethromycin. Antimicrob. Agents Chemother. 49: 2372-2377 [Abstract] [Full Text]  
  • Labro, M. T., Abdelghaffar, H., Babin-Chevaye, C. (2004). Interaction of the New Ketolide ABT-773 (Cethromycin) with Human Polymorphonuclear Neutrophils and the Phagocytic Cell Line PLB-985 In Vitro. Antimicrob. Agents Chemother. 48: 1096-1104 [Abstract] [Full Text]  
  • Garcia, I., Pascual, A., Ballesta, S., del Castillo, C., Perea, E. J. (2003). Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytes. J Antimicrob Chemother 52: 24-28 [Abstract] [Full Text]  
  • Seral, C., Michot, J.-M., Chanteux, H., Mingeot-Leclercq, M.-P., Tulkens, P. M., Van Bambeke, F. (2003). Influence of P-Glycoprotein Inhibitors on Accumulation of Macrolides in J774 Murine Macrophages. Antimicrob. Agents Chemother. 47: 1047-1051 [Abstract] [Full Text]  
  • Vazifeh, D., Abdelghaffar, H., Labro, M. T. (2002). Effect of Telithromycin (HMR 3647) on Polymorphonuclear Neutrophil Killing of Staphylococcus aureus in Comparison with Roxithromycin. Antimicrob. Agents Chemother. 46: 1364-1374 [Abstract] [Full Text]  
  • Muller-Serieys, C., Soler, P., Cantalloube, C., Lemaitre, F., Gia, H. P., Brunner, F., Andremont, A. (2001). Bronchopulmonary Disposition of the Ketolide Telithromycin (HMR 3647). Antimicrob. Agents Chemother. 45: 3104-3108 [Abstract] [Full Text]  
  • Abdelghaffar, H., Vazifeh, D., Labro, M. T. (2001). Cellular Uptake of Two Fluoroketolides, HMR 3562 and HMR 3787, by Human Polymorphonuclear Neutrophils In Vitro. Antimicrob. Agents Chemother. 45: 2798-2806 [Abstract] [Full Text]  
  • Mandell, G. L., Coleman, E. (2001). Uptake, Transport, and Delivery of Antimicrobial Agents by Human Polymorphonuclear Neutrophils. Antimicrob. Agents Chemother. 45: 1794-1798 [Abstract] [Full Text]  
  • Gustafsson, I., Engstrand, L., Cars, O. (2001). In Vitro Pharmacodynamic Studies of Activities of Ketolides HMR 3647 (Telithromycin) and HMR 3004 against Extracellular or Intracellular Helicobacter pylori. Antimicrob. Agents Chemother. 45: 353-355 [Abstract] [Full Text]  
  • Maurin, M., Mersali, N. F., Raoult, D. (2000). Bactericidal Activities of Antibiotics against Intracellular Francisella tularensis. Antimicrob. Agents Chemother. 44: 3428-3431 [Abstract] [Full Text]  
  • Labro, M.-T. (2000). Interference of Antibacterial Agents with Phagocyte Functions: Immunomodulation or ""Immuno-Fairy Tales""?. Clin. Microbiol. Rev. 13: 615-650 [Abstract] [Full Text]  
  • Rastogi, N., Goh, K. S., Berchel, M., Bryskier, A. (2000). In Vitro Activities of the Ketolides Telithromycin (HMR 3647) and HMR 3004 Compared to Those of Clarithromycin against Slowly Growing Mycobacteria at pHs 6.8 and 7.4. Antimicrob. Agents Chemother. 44: 2848-2852 [Abstract] [Full Text]  
  • Mandell, G. L., Coleman, E. J. (2000). Activities of Antimicrobial Agents against Intracellular Pneumococci. Antimicrob. Agents Chemother. 44: 2561-2563 [Abstract] [Full Text]  
  • Baltch, A. L., Smith, R. P., Ritz, W. J., Franke, M. A., Michelsen, P. B. (2000). Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila. J Antimicrob Chemother 46: 51-55 [Abstract] [Full Text]  
  • Gustafsson, I., Hjelm, E., Cars, O. (2000). In Vitro Pharmacodynamics of the New Ketolides HMR 3004 and HMR 3647 (Telithromycin) against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 44: 1846-1849 [Abstract] [Full Text]  
  • Munckhof, W. J., Borlace, G., Turnidge, J. D. (2000). Postantibiotic Suppression of Growth of Erythromycin A-Susceptible and -Resistant Gram-Positive Bacteria by the Ketolides Telithromycin (HMR 3647) and HMR 3004. Antimicrob. Agents Chemother. 44: 1749-1753 [Abstract] [Full Text]  
  • Vazifeh, D., Bryskier, A., Labro, M. T. (2000). Effect of Proinflammatory Cytokines on the Interplay between Roxithromycin, HMR 3647, or HMR 3004 and Human Polymorphonuclear Neutrophils. Antimicrob. Agents Chemother. 44: 511-521 [Abstract] [Full Text]  
  • Edelstein, P. H., Edelstein, M. A. C. (1999). In Vitro Activity of the Ketolide HMR 3647 (RU 6647) for Legionella spp., Its Pharmacokinetics in Guinea Pigs, and Use of the Drug To Treat Guinea Pigs with Legionella pneumophila Pneumonia. Antimicrob. Agents Chemother. 43: 90-95 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»